Literature DB >> 23918113

Management of hyponatremia in the ICU.

Richard H Sterns1, John K Hix2, Stephen M Silver2.   

Abstract

Hyponatremia is common in critical care units. Avoidance of neurologic injury requires a clear understanding of why the serum sodium (Na) concentration falls and why it rises, how the brain responds to a changing serum Na concentration, and what the goals of therapy should be. A 4 to 6 mEq/L increase in serum Na concentration is sufficient to treat life-threatening cerebral edema caused by acute hyponatremia. In chronic (> 48 h), severe (< 120 mEq/L) hyponatremia, correction by > 8 to 10 mEq/L/d risks iatrogenic osmotic demyelination syndrome (ODS); therefore, a 4 to 6 mEq/L daily increase in serum Na concentration should be the goal in most patients. With the possible exception of hyponatremia caused by heart failure or hepatic cirrhosis, a rapid initial increase in serum Na for severe symptoms and avoidance of overcorrection are best achieved with 3% saline given in either a peripheral or central vein. Inadvertent overcorrection can be avoided in high-risk patients with chronic hyponatremia by administration of desmopressin to prevent excessive urinary water losses. In patients with hyponatremia with oliguric kidney failure, controlled correction can be achieved with modified hemodialysis or continuous renal replacement therapies. ODS is potentially reversible, even in severely affected patients who are quadriplegic, unresponsive, and ventilator dependent. Supportive care should be offered several weeks before concluding that the condition is hopeless.

Entities:  

Mesh:

Year:  2013        PMID: 23918113     DOI: 10.1378/chest.12-2600

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Impact of perioperative hyponatremia in children: A narrative review.

Authors:  Cheme Andersen; Arash Afshari
Journal:  World J Crit Care Med       Date:  2014-11-04

2.  Osmotic demyelination syndrome in a patient with Noonan syndrome and anterior hypopituitarism.

Authors:  Tzy Harn Chua; Wann Jia Loh
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-08-20

3.  Central Pontine Myelinosis and Osmotic Demyelination Syndrome.

Authors:  Johann Lambeck; Maren Hieber; Andrea Dreßing; Wolf-Dirk Niesen
Journal:  Dtsch Arztebl Int       Date:  2019-09-02       Impact factor: 5.594

Review 4.  [Hyponatremia-workflow for intensive care physicians].

Authors:  C Hafer
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-12-02       Impact factor: 0.840

5.  The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients.

Authors:  Ramy Magdy Hanna; Wan-Ting Yang; Eduardo A Lopez; Joseph Nabil Riad; James Wilson
Journal:  Clin Kidney J       Date:  2016-05-24

6.  Efficacy of oral tolvaptan versus 3% hypertonic saline for correction of hyponatraemia in post-operative patients.

Authors:  Pulak Tosh; Sunil Rajan; Dilesh Kadapamannil; Nandhini Joseph; Lakshmi Kumar
Journal:  Indian J Anaesth       Date:  2017-12

7.  The Incidence and Risk Factors of Hyponatremia in Pulmonary Tuberculosis.

Authors:  Tomohiko Yoshida; Hidenori Masuyama; Hiroki Yamagata; Makoto Miyabayashi; Shunichiro Onishi; Yosuke Inaba; Minoru Takemoto
Journal:  J Endocr Soc       Date:  2022-08-25

8.  Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?

Authors:  Cédric Rafat; Martin Flamant; Stéphane Gaudry; Emmanuelle Vidal-Petiot; Jean-Damien Ricard; Didier Dreyfuss
Journal:  Ann Intensive Care       Date:  2015-11-09       Impact factor: 6.925

9.  Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan.

Authors:  Sunil Rajan; Pulak Tosh; Dilesh Kadapamannil; Soumya Srikumar; Jerry Paul; Lakshmi Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Apr-Jun

10.  Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on electrolyte and acid-base variables in dogs with suspected intracranial hypertension.

Authors:  Sabrina N Hoehne; Ivayla D Yozova; Beatriz Vidondo; Katja N Adamik
Journal:  J Vet Intern Med       Date:  2020-11-25       Impact factor: 3.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.